Cbl-b-dependent degradation of FLIPL is involved in ATO-induced autophagy in leukemic K562 and gastric cancer cells

FEBS Letters

Volumn 586, Issue 19, 2012, Pages 3104-3110

  Zhang, Guodong ^a   Liu, Jing ^a   Zhang, Ye ^a   Qu, Jinglei ^a   Xu, Ling ^a   Zheng, Huachuan ^a   Liu, Yunpeng ^a   Qu, Xiujuan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Arsenic trioxide; Autophagy; Cbl b; FLIPL

Indexed keywords

ARSENIC TRIOXIDE; CASITAS B LINEAGE LYMPHOMA B PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN; LONG FLICE LIKE INHIBITORY PROTEIN; PROTEASOME; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL; CELL STRAIN K 562; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STOMACH CANCER; UBIQUITINATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ARSENICALS; AUTOPHAGY; BASE SEQUENCE; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; JURKAT CELLS; K562 CELLS; LEUKEMIA; OXIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-CBL; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; UBIQUITIN;

EID: 84866629897     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.07.067     Document Type: Article

References (39)

1. J.R. Berenson Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single-arm study Br. J. Haematol. 135 2006 174 183
2. Z.Y. Wang, and Z. Chen Acute promyelocytic leukemia: from highly fatal to highly curable Blood 111 2008 2505 2515
3. W.L. Zheng, G.S. Zhang, Y.X. Xu, J.K. Shen, C.W. Dai, and M.F. Pei Arsenic trioxide, thalidomide and retinoid acid combination therapy in higher risk myelodysplastic syndrome patients Leuk. Res. 32 2008 251 254
4. G. Kchour Phase II study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic ATL Blood 113 2009 6528 6532
5. J. Vuky, R. Yu, L. Schwartz, and R.J. Motzer Phase II trial of arsenic trioxide in patients with metastatic renal cell carcinoma Invest. New Drugs 20 2002 327 330
6. W. Guo, X.D. Tang, S. Tang, and Y. Yang Preliminary report of combination chemotherapy including Arsenic trioxide for stage III osteosarcoma and Ewing sarcoma Zhonghua Wai Ke Za Zhi 44 2006 805 808
7. C.C. Lin, C. Hsu, C.H. Hsu, W.L. Hsu, A.L. Cheng, and C.H. Yang Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial Invest. New Drugs 25 2007 77 84
8. A.A. Tarhini, J.M. Kirkwood, H. Tawbi, W.E. Gooding, M.F. Islam, and S.S. Agarwala Safety and efficacy of arsenic trioxide for patients with advanced metastatic melanoma Cancer 112 2008 1131 1138
9. A. Emadi, and S.D. Gore Arsenic trioxide-an old drug rediscovered Blood Rev. 24 2010 191 199
10. T. Kanzawa, Y. Kondo, H. Ito, S. Kondo, and I. Germano Induction of autophagic cell death in malignant glioma cells by arsenic trioxide Cancer Res. 63 2003 2103 2108
11. W. Qian, J. Liu, J. Jin, W. Ni, and W. Xu Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1 Leuk. Res. 31 2007 329 339
12. D.J. Goussetis, J.K. Altman, H. Glaser, J.L. McNeer, M.S. Tallman, and L.C. Platanias Autophagy is a critical mechanism for the induction of the antileukemic effects of arsenic trioxide J. Biol. Chem. 285 2010 29989 29997
13. M. Irmler Inhibition of death receptor signals by cellular FLIP Nature 388 1997 190 195
14. D.B. Longley, T.R. Wilson, M. McEwan, W.L. Allen, U. McDermott, L. Galligan, and P.G. Johnston C-FLIP inhibits chemotherapy-induced colorectal cancer cell death Oncogene 25 2006 838 848
15. J.S. Lee FLIP-mediated autophagy regulation in cell death control Nat. Cell Biol. 11 2009 1355 1362
16. D.M. Kerbauy, V. Lesnikov, N. Abbasi, S. Seal, B. Scott, and H.J. Deeg NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs) Blood 106 2005 3917 3925
17. C.B. Thien, and W.Y. Langdon Cbl: many adaptations to regulate protein tyrosine kinases Nat. Rev. Mol. Cell Biol. 2 2001 294 307
18. N. Rao, I. Dodge, and H. Band The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system J. Leukoc. Biol. 71 2002 753 763
19. M.P. Oksvold, C.B. Thien, J. Widerberg, A. Chantry, H.S. Huitfeldt, and W.Y. Langdon Serine mutations that abrogate ligand-induced ubiquitination and internalization of the EGF receptor do not affect c-Cbl association with the receptor Oncogene 22 2003 8509 8518
20. M.H. Schmidt, and I. Dikic The Cbl interactome and its functions Nat. Rev. Mol. Cell Biol. 6 2005 907 919
21. M. Kundu A TNF-and c-Cbl-dependent FLIP(S)-degradation pathway and its function in Mycobacterium tuberculosis-induced macrophage apoptosis Nat. Immunol. 10 2009 918 926
22. E. Sandilands Autophagic targeting of Src promotes cancer cell survival following reduced FAK signalling Nat. Cell Biol. 14 2011 51 60
23. Y. Li, X. Qu, J. Qu, Y. Zhang, J. Liu, Y. Teng, X. Hu, K. Hou, and Y. Liu Arsenic trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to inhibit PI3K/Akt signaling and thereby regulate p53 activation Cancer Lett. 284 2009 208 215
24. X. Qu, Y. Zhang, Y. Li, X. Hu, Y. Xu, L. Xu, K. Hou, K. Sada, and Y. Liu Ubiquitin ligase Cbl-b sensitizes leukemia and gastric cancer cells to anthracyclines by activating the mitochondrial pathway and modulating Akt and ERK survival signals FEBS Lett. 583 2009 2255 2262
25. S. Pankiv, T.H. Clausen, T. Lamark, A. Brech, J.A. Bruun, H. Outzen, A. Overvatn, G. Bjorkoy, and T. Johansen P62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy J. Biol. Chem. 282 2007 24131 24145
26. N. Mizushima, T. Yoshimori, and B. Levine Methods in mammalian autophagy research Cell 140 2010 313 326
27. J.V. Abella, P. Peschard, M.A. Naujokas, T. Lin, C. Saucier, S. Urbé, and M. Park Met/Hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation Mol. Cell. Biol. 25 2005 9632 9645
28. X. Li, and Z. Fan The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1{alpha} and Bcl-2 and activating the beclin 1/hVps34 complex Cancer Res. 70 2010 5942 5952
29. R. Mathew, V. Karantza-Wadsworth, and E. White Role of autophagy in cancer Nat. Rev. Cancer 7 2007 961 967
30. T. Kanzawa, L. Zhang, L. Xiao, I.M. Germano, Y. Kondo, and S. Kondo Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3 Oncogene 24 2005 980 991
31. P. Isakson, M. Bjorås, S.O. Boe, and A. Simonsen Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein Blood 116 2010 2324 2331
32. H.W. Chiu, S.Y. Ho, H.R. Guo, and Y.J. Wang Combination treatment with arsenic trioxide and irradiation enhances autophagic effects in U118-MG cells through increased mitotic arrest and regulation of PI3K/Akt and ERK1/2 signaling pathways Autophagy 5 2009 472 483
33. O. Micheau, M. Thome, P. Schneider, N. Holler, J. Tschopp, D.W. Nicholson, C. Briand, and M.G. Grütter The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex J. Biol. Chem. 277 2002 45162 45171
34. D.A. Sharp, D.A. Lawrence, and A. Ashkenazi Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis J. Biol. Chem. 280 2005 19401 19409
35. T.R. Wilson, K.M. McLaughlin, M. McEwan, H. Sakai, K.M. Rogers, K.M. Redmond, P.G. Johnston, and D.B. Longley C-FLIP: a key regulator of colorectal cancer cell death Cancer Res. 67 2007 5754 5762
36. L. Chang, H. Kamata, G. Solinas, J.L. Luo, S. Maeda, K. Venuprasad, Y.C. Liu, and M. Karin The E3 ubiquitin ligase Itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP (L) turnover Cell 124 2006 601 613
37. M. Paolino, C.B. Thien, T. Gruber, R. Hinterleitner, G. Baier, W.Y. Langdon, and J.M. Penninger Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions J. Immunol. 186 2011 2138 2147
38. S.A. Ettenberg, A. Magnifico, M. Cuello, M.M. Nau, Y.R. Rubinstein, Y. Yarden, A.M. Weissman, and S. Lipkowitz Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex J. Biol. Chem. 276 2001 27677 27684
39. Y. Kobashigawa, A. Tomitaka, H. Kumeta, N.N. Noda, M. Yamaguchi, and F. Inagaki Autoinhibition and phosphorylation-induced activation mechanisms of human cancer and autoimmune disease-related E3 protein Cbl-b Proc. Natl. Acad. Sci. U S A 108 2011 20579 20584